D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 19,954 370 World Ranking 9360 National Ranking 4973

Research.com Recognitions

Awards & Achievements

1964 - Fellow of the Royal Society of Canada Academy of Science

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

His scientific interests lie mostly in Kinase, Alzheimer's disease, Cancer research, Biochemistry and Pharmacology. Charles D. Smith interconnects Ceramide, Signal transduction and Cell growth in the investigation of issues within Kinase. The various areas that he examines in his Ceramide study include Sphingosine, Sphingosine Kinase 2, Sphingosine kinase and Cell biology.

His Alzheimer's disease research includes elements of Hippocampal sclerosis, Biomarker and Neuroscience. He has included themes like Molecular biology, Cell culture, Paclitaxel and Colchicine in his Biochemistry study. His biological study spans a wide range of topics, including Apoptosis, Cell, Sorafenib and In vivo.

His most cited work include:

  • Discovery and evaluation of inhibitors of human sphingosine kinase. (541 citations)
  • Chemoattractant receptor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate in human polymorphonuclear leukocyte membranes. Requirement for a guanine nucleotide regulatory protein. (298 citations)
  • Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. (297 citations)

What are the main themes of his work throughout his whole career to date?

Charles D. Smith mainly investigates Disease, Internal medicine, Pharmacology, Cancer research and Biochemistry. His Disease study also includes

  • Magnetic resonance imaging and related Pathology,
  • Audiology together with Electroencephalography. The various areas that he examines in his Internal medicine study include Endocrinology, Oncology and Cardiology.

His studies examine the connections between Pharmacology and genetics, as well as such issues in Sphingosine kinase, with regards to Immunology. His Cancer research study also includes fields such as

  • Sphingosine which is related to area like Ceramide and Cell growth,
  • Kinase which connect with Phosphorylation. His Alzheimer's disease research focuses on Dementia and how it connects with Neuropathology.

He most often published in these fields:

  • Disease (13.03%)
  • Internal medicine (12.56%)
  • Pharmacology (11.37%)

What were the highlights of his more recent work (between 2015-2021)?

  • Artificial intelligence (8.53%)
  • Pattern recognition (5.45%)
  • Disease (13.03%)

In recent papers he was focusing on the following fields of study:

Charles D. Smith mainly focuses on Artificial intelligence, Pattern recognition, Disease, Hyperintensity and Internal medicine. His research in Disease is mostly focused on Alzheimer's disease. His study in Alzheimer's disease is interdisciplinary in nature, drawing from both Cognitive reserve and Allele.

In his study, Pathology, Diffusion MRI, Fluid-attenuated inversion recovery and Default mode network is inextricably linked to White matter, which falls within the broad field of Hyperintensity. Charles D. Smith interconnects Endocrinology, Oncology and Cardiology in the investigation of issues within Internal medicine. His work carried out in the field of Neuroscience brings together such families of science as Neuropathology and Dementia.

Between 2015 and 2021, his most popular works were:

  • Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology. (124 citations)
  • "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). (88 citations)
  • A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors. (72 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

Disease, Alzheimer's disease, Dementia, Neuroscience and Magnetic resonance imaging are his primary areas of study. His Alzheimer's disease research incorporates elements of Fractional anisotropy and Diffusion MRI. His Dementia study incorporates themes from Hippocampal sclerosis, Cohort and Cognitive test.

His Neuroscience study frequently draws connections between related disciplines such as Neuropathology. His research integrates issues of Internal medicine and Pathology in his study of Magnetic resonance imaging. His studies deal with areas such as Endocrinology and Protein phosphatase 1 as well as Internal medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Discovery and evaluation of inhibitors of human sphingosine kinase.

Kevin J. French;Randy S. Schrecengost;Brian D. Lee;Yan Zhuang.
Cancer Research (2003)

757 Citations

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez.
Nature Communications (2016)

720 Citations

Chemoattractant receptor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate in human polymorphonuclear leukocyte membranes. Requirement for a guanine nucleotide regulatory protein.

C D Smith;B C Lane;I Kusaka;M W Verghese.
Journal of Biological Chemistry (1985)

454 Citations

Receptor-coupled activation of phosphoinositide-specific phospholipase C by an N protein

Charles D. Smith;C. Christine Cox;Ralph Snyderman.
Science (1986)

432 Citations

Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.

Arati Sharma;Nishit R. Trivedi;Melissa A. Zimmerman;David A. Tuveson.
Cancer Research (2005)

422 Citations

Welwitindolinones, Unusual Alkaloids from the Blue-Green Algae Hapalosiphon welwitschii and Westiella intricata. Relationship to Fischerindoles and Hapalinodoles

Klemens Stratmann;Richard E. Moore;Rosanne Bonjouklian;Jack B. Deeter.
Journal of the American Chemical Society (1994)

407 Citations

Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2

Kevin J. French;Yan Zhuang;Lynn W. Maines;Peng Gao.
Journal of Pharmacology and Experimental Therapeutics (2010)

375 Citations

Antitumor activity of sphingosine kinase inhibitors

Kevin J. French;John J. Upson;Staci N. Keller;Yan Zhuang.
Journal of Pharmacology and Experimental Therapeutics (2006)

333 Citations

Cryptophycin: A New Antimicrotubule Agent Active against Drug-resistant Cells

Charles D. Smith;Xinqun Zhang;Susan L. Mooberry;Gregory M.L. Patterson.
Cancer Research (1994)

295 Citations

Reduction of TRAIL-Induced Mcl-1 and cIAP2 by c-Myc or Sorafenib Sensitizes Resistant Human Cancer Cells to TRAIL-Induced Death

M. Stacey Ricci;Seok Hyun Kim;Kazuhiro Ogi;John P. Plastaras.
Cancer Cell (2007)

295 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Charles D. Smith

Lina M. Obeid

Lina M. Obeid

Stony Brook University

Publications: 61

Dennis W. Dickson

Dennis W. Dickson

Mayo Clinic

Publications: 57

Julie A. Schneider

Julie A. Schneider

Rush University Medical Center

Publications: 56

Stuart M. Pitson

Stuart M. Pitson

University of South Australia

Publications: 56

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 53

David A. Bennett

David A. Bennett

Rush University Medical Center

Publications: 50

Nigel J. Pyne

Nigel J. Pyne

University of Strathclyde

Publications: 48

Sarah Spiegel

Sarah Spiegel

Virginia Commonwealth University

Publications: 48

Susan Pyne

Susan Pyne

University of Strathclyde

Publications: 48

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 44

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 40

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 38

Nigel J. Cairns

Nigel J. Cairns

University of Exeter

Publications: 36

Anders M. Dale

Anders M. Dale

University of California, San Diego

Publications: 34

Harald Hampel

Harald Hampel

Eisai (United States)

Publications: 34

Michael W. Weiner

Michael W. Weiner

University of California, San Francisco

Publications: 33

Trending Scientists

Joost-Pieter Katoen

Joost-Pieter Katoen

RWTH Aachen University

Vladimir Kolmogorov

Vladimir Kolmogorov

Institute of Science and Technology Austria

Avideh Zakhor

Avideh Zakhor

University of California, Berkeley

Hamed Mohsenian-Rad

Hamed Mohsenian-Rad

University of California, Riverside

Tharmalingam Punniyamurthy

Tharmalingam Punniyamurthy

Indian Institute of Technology Guwahati

John Wang

John Wang

National University of Singapore

Alexander Star

Alexander Star

University of Pittsburgh

Vincent Lombard

Vincent Lombard

Aix-Marseille University

Malek Bajbouj

Malek Bajbouj

Charité - University Medicine Berlin

Harvey M. Friedman

Harvey M. Friedman

University of Pennsylvania

Frank Larøi

Frank Larøi

University of Bergen

Janis H. Crowther

Janis H. Crowther

Kent State University

Dalun Zhang

Dalun Zhang

Texas A&M University

Peter Rosenbaum

Peter Rosenbaum

McMaster University

Hussein Kassim

Hussein Kassim

University of East Anglia

Something went wrong. Please try again later.